arrow
Back
A

Antonio Llombart‐Cussac

fisabio

59H-index
695Paper Count
1.6WCitation Count
Published Papers 211
Publication Date
Modulation of the response to immunotherapy in triple-negative breast cancer: the role of the microbiota and microbial metabolites in the tumor microenvironment
err2026-07-08
err0
errOAAI
errLucía Serrano-García; Elisabeth Martínez-Salvador; Ana Belda-Marco; Clara Herrero-Oliva; Javier Cortés; Antonio Llombart-Cussac; Leonor Fernández-Murga
errShare
errSave
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer: Updated Efficacy Results from the phase 3 EMBER-3 trial
err2025-12-12
err0
errOAAI
errK.L. Jhaveri; P. Neven; M.L. Casalnuovo; S-B. Kim; E. Tokunaga; P. Aftimos; C. Saura; J. O’Shaughnessy; N. Harbeck; L.A. Carey; G. Curigliano; J. Watanabe; E. Lim; J. Huang; Z. Qingyuan; A. Llombart-Cussac; C. Huang; B. Desai; Y. Limay; X.A. Wang
errShare
errSave
Comparing [18F]FDG–positron emission tomography and breast magnetic resonance imaging to predict pathological complete response and 3-year invasive disease-free survival in HER2-positive early breast cancer patients: an unplanned exploratory analysis of the PHERGain trial☆
err2025-11-06
err0
errOAAI
errJ.J. García-Mosquera; J.M. Pérez-García; M. Ruiz-Borrego; A. Stradella; B. Bermejo; S. Escrivá-de-Romaní; L. Calvo Martínez; G. Gebhart; K. Kerrou; M. Gion; G. Antonarelli; S. Santasusagna Canal; J. Rodríguez-Morato; L. Mina; M. Sampayo-Cordero; A. Llombart-Cussac; J. Cortés
errShare
errSave
The Impact on the Therapeutic Decision of Massive Gene Sequencing (NGS) in Plasma from Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
err2025-10-29
err0
errOAAI
errPaula Llor-Rodriguez; Ana Blasco-Cordellat; Sonia Macia-Escalante; Leonor Fernández-Murga; José Vidal-Martinez; Javier Garde-Noguera; José García-Sánchez; Antonio Llombart-Cussac
errShare
errSave
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial
err2025-10-27
err0
PREAI
errThorsten Fuereder; Javier Garde-Noguera; Juan José García-Mosquera; Manuel Ruiz-Borrego; María Valero; Antonio Llombart-Cussac; María Gion; Richard Greil; Miriam Arumi; Marta Campolier; José Antonio Guerrero; Giulia Raimondi; Mario Mancino; Carlos Jiménez-Cortegana; Marta Vaz-Batista; Felicitas Oberndorfer; Maximilian Marhold; Anna Sophie Berghoff; Julia Furtner; Rupert Bartsch; Matthias Preusser
errShare
errSave
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial
err2025-10-27
err0
PREAI
errRupert Bartsch; Maximilian Marhold; Javier Garde-Noguera; María Gion; Manuel Ruiz-Borrego; Richard Greil; María Valero; Antonio Llombart-Cussac; Juan José García-Mosquera; Miriam Arumi; Javier Cortés; Marta Campolier; José Antonio Guerrero; Felipe Slebe; Elena Martínez-García; Carlos Jiménez-Cortegana; Marta Vaz-Batista; Felicitas Oberndorfer; Julia Furtner; Thorsten Fuereder; Anna Sophie Berghoff; Matthias Preusser
errShare
errSave
Corrigendum to “Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3”
err2025-10-15
err0
errOAAI
errM.P. Goetz; M. Toi; J. Huober; J. Sohn; O. Trédan; I.H. Park; M. Campone; S.-C. Chen; L.M. Manso; S. Paluch-Shimon; O.C. Freedman; J. O’Shaughnessy; X. Pivot; S.M. Tolaney; S.A. Hurvitz; A. Llombart-Cussac; V. André; A. Saha; G. van Hal; A. Shahir; H. Iwata; S.R.D. Johnston
errShare
errSave
Immunogenicity of SARS-CoV-2 mRNA Vaccine in Breast Cancer Patients Undergoing Active Treatment: A Prospective Observational Study
err2025-09-30
err0
errOAAI
errMaría Leonor Fernández-Murga; Lucía Serrano-García; Giuseppe D’Auria; María Portero Hernández; Llúcia Martínez-Priego; Loreto Ferrús-Abad; Griselda de Marco; María Victoria Domínguez-Márquez; Antonio Llombart-Cussac
errShare
errSave
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis
err2025-07-14
err0
PREAI
errGuillermo Villacampa; Tomás Pascual; Paolo Tarantino; Javier Cortés; José Perez-García; Antonio Llombart-Cussac; Pierfranco Conte; Mario Mancino; Valentina Guarneri; Maria Vittoria Dieci; Adrienne G Waks; Francesco Schettini; Fara Brasó-Maristany; Gaia Griguolo; Beatriz Alonso de Castro; Cristina Reboredo; Silvia Antolín; Coralia Bueno-Muiño; Isabel Echavarría; Sara López-Tarruella; Tatiana Massarrah; María del Monte-Millán; Miguel Martín; Wesley Buckingham; Joel S Parker; Ana Vivancos; Kornelia Polyak; Otto Metzger Filho; Antonio C Wolff; Angela DeMichele; Nadine M Tung; Charles M Perou; Laia Paré; Patricia Villagrasa; Aleix Prat; Sara M Tolaney
errShare
errSave
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial
err2025-07-01
err0
PREAI
errJosé Manuel Pérez-García; María Gion; Manuel Ruiz-Borrego; Isabel Blancas; Elena López-Miranda; Salvador Blanch; Sabela Recalde; Cristina Reboredo Rendo; Xavier González; Nerea Ancizar; Serafin Morales; Patricia Cortez; Zuzanna Piwowarska; Eileen Shimizu; José Antonio Guerrero; Miguel Sampayo-Cordero; Alejandro Martínez-Bueno; Javier Cortés; Antonio Llombart-Cussac
errShare
errSave
Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial☆
err2025-07-01
err0
PREAI
errA. Llombart-Cussac; J.M. Pérez-García; M. Bellet; F. Dalenc; M. Gil-Gil; M. Ruiz-Borrego; J. Gavila; P. Schmid; P. Zamora; D. Wheatley; E. Martínez-de Dueñas; K. Amillano; S. Di Cosimo; A. Anton; P. Cottu; E. Shimizu; M. Fernandez; M. Sampayo-Cordero; J. Cortés
errShare
errSave
Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial
err2025-06-20
err0
errOAAI
errJoan Albanell; Angelo Gámez Pozo; Carlos L. Arteaga; Meritxell Bellet; Federico Rojo; Abel González; Beatriz Bellosillo; Violeta Serra; Petra Gener; José Antonio Guerrero; Eileen Shimizu; Mario Mancino; Jose Rodríguez-Morató; Leonardo Mina; José Manuel Pérez-García; Javier Cortés; Antonio Llombart-Cussac
errShare
errSave
Advancing breast cancer therapy in the era of molecular diagnostics
err2025-05-08
err0
errOAAI
errMaria Grazia Carnevale; Riccardo Ray Colciago; Maria Carmen De Santis; Laura Cortesi; Cinzia De Marco; Antonio Marra; Andrea Vingiani; Franco Nolè; Giuseppe Curigliano; Giancarlo Pruneri; Antonio Llombart-Cussac; Serena Di Cosimo; Javier Cortes
errShare
errSave
Gene Expression Signatures for Guiding Initial Therapy in ER+/HER2-Early Breast Cancer
errCANCERS
IF4.4
err2025-04-28
err0
errOAAI
errMarin-Liebana, Sara; Llor, Paula; Serrano-Garcia, Lucia; Fernandez-Murga, Maria Leonor; Comes-Raga, Ana; Torregrosa, Dolores; Perez-Garcia, Jose Manuel; Cortes, Javier; Llombart-Cussac, Antonio
errShare
errSave
Decreased gene expression of interleukin 2 receptor subunit γ (CD132) in tissues of patients with Crohn's disease
err2025-03-28
err1
PREAI
errAndreu-Ballester, Juan Carlos; Hurtado-Marcos, Carolina; Garcia-Ballesteros, Carlos; Perez-Griera, Jaime; Izquierdo, Fernando; Ollero, Dolores; Jimenez, Ana; Gil-Borras, Rafael; Llombart-Cussac, Antonio; Lopez-Chulia, Francisca; Cuellar, Carmen
errShare
errSave
Second-Line Treatment Options for Patients with Metastatic Triple-Negative Breast Cancer: A Review of the Clinical Evidence ( jan , 10.1007/s11523-024-01125-1 , 2025)
err2025-03-01
err0
errOAAI
errGarcia-Saenz, Jose angel; Rodriguez-Lescure, Alvaro; Cruz, Josefina; Albanell, Joan; Alba, Emilio; Llombart, Antonio
errShare
errSave
Second-Line Treatment Options for Patients with Metastatic Triple-Negative Breast Cancer: A Review of the Clinical Evidence
err2025-01-13
err1
PREAI
errGarcia-Saenz, Jose angel; Rodriguez-Lescure, Alvaro; Cruz, Josefina; Albanell, Joan; Alba, Emilio; Llombart, Antonio
errShare
errSave
Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis
err2025-01-01
err0
errOAAI
errBartsch, R.; Perez-Garcia, J. M.; Furtner, J.; Berghoff, A. S.; Marhold, M.; Starzer, A. M.; Hughes, M.; Kabraji, S.; Sammons, S.; Anders, C.; Murthy, R. K.; Swearingen, A. E. D. Van; Pereslete, A.; Gion, M.; Batista, M. Vaz; Braga, S.; Pinto, P. B. C.; Sampayo-Cordero, M.; Llombart-Cussac, A.; Preusser, M.; Cortes, J.; Lin, N. U.
errShare
errSave
Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review
err2024-12-13
err0
errOAAI
errSerrano Garcia, Lucia; Javega, Beatriz; Llombart Cussac, Antonio; Gion, Maria; Perez-Garcia, Jose Manuel; Cortes, Javier; Fernandez-Murga, Maria Leonor
errShare
errSave
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study
errBREAST
IF7.9
err2024-12-01
err0
errOAAI
errCortes, Alfonso; Lopez-Miranda, Elena; Fernandez-Ortega, Adela; Caranana, Vicente; Servitja, Sonia; Urruticoechea, Ander; Lema-Roso, Laura; Marquez, Antonia; Lazaris, Alexandros; Alcala-Lopez, Daniel; Mina, Leonardo; Gener, Petra; Rodriguez-Morato, Jose; Antonarellij, Gabriele; Llombart-Cussac, Antonio; Perez-Garcia, Jose; Cortes, Javier
errShare
errSave